Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

India Glycols Earnings Call: Key Takeaways

India Glycols delivered strong FY26 performance with 11.8% Net Revenue growth and 26.8% PAT growth. Management is executing a three-way demerger into Chemicals, Spirits/Bio-Fuel, and Bio-Pharma entities.

Why this was an Alfa AlertNot a filter event. Results show strong growth but no explicit prior management guidance range was provided for comparison.
Highlights
Revenue growth11.8% YoY for FY26; 13.1% YoY for Q4FY26.
MarginsEBITDA margin improved to 15.5% in FY26 (+162 bps).
Demand visibilitySoftening in some end-user markets due to geopolitical situation.
Management confidenceHigh; citing strategic positioning and diverse product portfolio.

Growth

FY26: Net Revenue ₹4,211Cr (+11.8% YoY), EBITDA ₹654Cr (+24.5%), PAT ₹293Cr (+26.8%). Q4FY26 PAT surged 35.7%.

Outlook

Demerger implementation scheduled for May 2026; targeting premiumization in spirits and expanding performance chemicals portfolio.

Risks

Geopolitical tensions affecting end-user demand; margin pressure in Ennature Biopharma segment; high raw material costs for seeds.

Source

Earnings Call filed with BSE, NSE: INDIAGLYCO. Summary written with AI assistance from the document.

Read the document ↗

India Glycols Ltd: key numbers

Share price
₹309.90
Market cap
₹2,077 Cr
Revenue (annual)
₹4,211 Cr
Net profit (annual)
₹292.8 Cr
P/E (TTM)
6.6×Sector 37.5×
Promoter holding
59.63%+0.00% QoQ
FII holding
2.24%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from India Glycols Ltd

All →
19:01 IST NSE
Board Meeting Outcome

India Glycols Board Meeting Outcome

India Glycols Limited announced that its subsidiary, IGL Spirits Limited, approved share allotment under a Scheme of Arrangement and appointed new key managerial personnel.